Anika Therapeutics, Inc. Announces Double Purchase

Anika Therapeutics, Inc. Announces Double Purchase

Anika Therapeutics, Inc. (NASDAQ: ANIK), a medical device company that develops therapeutic products for tissue protection, healing and repair, announced two acquisitions in mid-Januaryto bolster its device portfolio. For a modest sum of $35 million upfront and a potential $60 million in milestones, the company acquired Parcus Medical, LLC, which provides implant and instrumentation products used by surgeons to repair and reconstruct damaged ligaments and tendons due to sports injuries, trauma and disease. The deal will help expand Anika’s offerings into the ambulatory surgical center (ASC) market.  Parcus reported $12.5 million in revenue in 2019. Anika also acquired Arthrosurface for $60... Read More »